| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1495 | 2010 |
| Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1106 | 2017 |
| Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database UA Walker, A Tyndall, L Czirják, CP Denton, D Farge-Bancel, ... Annals of the rheumatic diseases 66 (6), 754-763, 2007 | 1092 | 2007 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 532 | 2017 |
| Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ... PloS one 11 (10), e0163894, 2016 | 222 | 2016 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 139 | 2016 |
| Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database B Maurer, N Graf, BA Michel, U Müller-Ladner, L Czirják, CP Denton, ... Annals of the rheumatic diseases 74 (6), 1124-1131, 2015 | 137 | 2015 |
| Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials D Khanna, CP Denton, PA Merkel, T Krieg, FO Le Brun, A Marr, ... Jama 315 (18), 1975-1988, 2016 | 127 | 2016 |
| Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma … W Wu, S Jordan, N Graf, J de Oliveira Pena, J Curram, Y Allanore, ... Annals of the rheumatic diseases 78 (5), 648-656, 2019 | 106 | 2019 |
| Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ... Annals of the rheumatic diseases 75 (7), 1285-1292, 2016 | 98 | 2016 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 92 | 2019 |
| ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis L Bütikofer, PA Varisco, O Distler, O Kowal-Bielecka, Y Allanore, ... Arthritis research & therapy 22, 1-9, 2020 | 53 | 2020 |
| New classification criteria for systemic lupus erythematosus correlate with disease activity F Anić, M Žuvić-Butorac, D Štimac, S Novak Croatian medical journal 55 (5), 514-519, 2014 | 51 | 2014 |
| Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ... Rheumatology 59 (7), 1684-1694, 2020 | 39 | 2020 |
| Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease? J Morović-Vergles, L Šalamon, D Marasović-Krstulović, T Kehler, D Šakić, ... Rheumatology international 33, 1185-1192, 2013 | 29 | 2013 |
| Extremely high serum ferritin levels as a main diagnostic tool of adult-onset Still’s disease S Novak, F Anic, TS Luke-Vrbanić Rheumatology international 32 (4), 1091-1094, 2012 | 25 | 2012 |
| García de la Peéa Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Ann Rheum Dis 76 (11), 1897, 1905 | 19 | 1905 |
| Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort E Zanatta, D Huscher, A Ortolan, J Avouac, P Airò, A Balbir-Gurman, ... Rheumatology 61 (12), 4786-4796, 2022 | 18 | 2022 |
| Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database M Hughes, C Heal, E Siegert, E Hachulla, P Airó, A Riccardi, O Distler, ... Annals of the rheumatic diseases 79 (8), 1123-1125, 2020 | 14 | 2020 |
| Antimicrobial prescribing at a university hospital: justified or ‘just in case’. Testing a new scoring system as a key quality indicator V Vlahović‐Palčevski, I Francetić, G Palčevski, S Novak, U Bergman Pharmacoepidemiology and drug safety 14 (8), 561-566, 2005 | 13 | 2005 |
Branimir Anićprofessor, Dept of Internal Medicine, Division for Clinical Immunology and Rheumatology, UHC Zagreb, University of Zagreb School of MedicineVerified email at mef.hr
